The nation of Zimbabwe has rejected a significant American health deal worth $367m (272 million pounds) over five years because of the United States' request for sensitive data.
This move came to light following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".
An official spokesman has since stated that the United States was seeking health data for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more talks to reach a agreement acceptable to all parties so the country's vital HIV programme can proceed.
Wider Background
This rejection comes after a comparable situation in neighbouring Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.
As per statements, Sixteen nations in Africa have so far signed similar health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to share its genetic material and health information for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our citizens if a new pandemic emerge."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining structures previously set up via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This mechanism is designed to guarantee that when a country provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our US partners on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body stated it understood the official position, but urged that negotiations need to persist since much of the country's HIV programmes depended on external financing.
"In cases where technical issues arise, including those involving data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group commented.
The halted deal underscores the ongoing challenges between accepting crucial international aid and protecting a country's data in an ever more interconnected world.